nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—kidney cancer—thyroid cancer	0.351	0.509	CtDrD
Gemcitabine—lung cancer—thyroid cancer	0.339	0.491	CtDrD
Gemcitabine—ABCC10—Doxorubicin—thyroid cancer	0.065	0.802	CbGbCtD
Gemcitabine—ABCB1—Sorafenib—thyroid cancer	0.00998	0.123	CbGbCtD
Gemcitabine—RRM1—larynx—thyroid cancer	0.00644	0.13	CbGeAlD
Gemcitabine—ABCB1—Doxorubicin—thyroid cancer	0.00606	0.0747	CbGbCtD
Gemcitabine—POLD1—neck—thyroid cancer	0.00334	0.0673	CbGeAlD
Gemcitabine—POLD1—saliva-secreting gland—thyroid cancer	0.0026	0.0525	CbGeAlD
Gemcitabine—POLE—saliva-secreting gland—thyroid cancer	0.00195	0.0393	CbGeAlD
Gemcitabine—SLC28A3—trachea—thyroid cancer	0.00184	0.0372	CbGeAlD
Gemcitabine—POLD1—thyroid gland—thyroid cancer	0.00159	0.0321	CbGeAlD
Gemcitabine—POLE—trachea—thyroid cancer	0.0015	0.0303	CbGeAlD
Gemcitabine—CDA—thyroid gland—thyroid cancer	0.00143	0.0288	CbGeAlD
Gemcitabine—POLD1—head—thyroid cancer	0.00141	0.0284	CbGeAlD
Gemcitabine—SLC29A2—thyroid gland—thyroid cancer	0.00133	0.0269	CbGeAlD
Gemcitabine—CMPK1—thyroid gland—thyroid cancer	0.00127	0.0256	CbGeAlD
Gemcitabine—POLE—thyroid gland—thyroid cancer	0.00119	0.024	CbGeAlD
Gemcitabine—CMPK1—head—thyroid cancer	0.00112	0.0227	CbGeAlD
Gemcitabine—POLE—head—thyroid cancer	0.00105	0.0213	CbGeAlD
Gemcitabine—DCK—saliva-secreting gland—thyroid cancer	0.00103	0.0209	CbGeAlD
Gemcitabine—POLA1—thyroid gland—thyroid cancer	0.00102	0.0207	CbGeAlD
Gemcitabine—POLD1—lymph node—thyroid cancer	0.000987	0.0199	CbGeAlD
Gemcitabine—ABCC10—saliva-secreting gland—thyroid cancer	0.000985	0.0199	CbGeAlD
Gemcitabine—RRM2—thyroid gland—thyroid cancer	0.000978	0.0197	CbGeAlD
Gemcitabine—RRM2—Afatinib—Vandetanib—thyroid cancer	0.000954	0.277	CbGdCrCtD
Gemcitabine—CDA—lymph node—thyroid cancer	0.000886	0.0179	CbGeAlD
Gemcitabine—RRM2—head—thyroid cancer	0.000868	0.0175	CbGeAlD
Gemcitabine—SLC29A1—trachea—thyroid cancer	0.000835	0.0168	CbGeAlD
Gemcitabine—RRM2—Gefitinib—Vandetanib—thyroid cancer	0.000834	0.242	CbGdCrCtD
Gemcitabine—SLC29A2—lymph node—thyroid cancer	0.000828	0.0167	CbGeAlD
Gemcitabine—RRM1—thyroid gland—thyroid cancer	0.000812	0.0164	CbGeAlD
Gemcitabine—DCK—trachea—thyroid cancer	0.000798	0.0161	CbGeAlD
Gemcitabine—CMPK1—lymph node—thyroid cancer	0.000787	0.0159	CbGeAlD
Gemcitabine—ABCC10—trachea—thyroid cancer	0.00076	0.0153	CbGeAlD
Gemcitabine—POLE—lymph node—thyroid cancer	0.000738	0.0149	CbGeAlD
Gemcitabine—TYMS—thyroid gland—thyroid cancer	0.000737	0.0149	CbGeAlD
Gemcitabine—RRM1—head—thyroid cancer	0.000721	0.0145	CbGeAlD
Gemcitabine—SLC29A1—thyroid gland—thyroid cancer	0.000661	0.0133	CbGeAlD
Gemcitabine—TYMS—head—thyroid cancer	0.000654	0.0132	CbGeAlD
Gemcitabine—POLA1—lymph node—thyroid cancer	0.000636	0.0128	CbGeAlD
Gemcitabine—DCK—thyroid gland—thyroid cancer	0.000631	0.0127	CbGeAlD
Gemcitabine—TYMS—Erlotinib—Vandetanib—thyroid cancer	0.000623	0.181	CbGdCrCtD
Gemcitabine—RRM2—lymph node—thyroid cancer	0.000608	0.0123	CbGeAlD
Gemcitabine—ABCC10—thyroid gland—thyroid cancer	0.000601	0.0121	CbGeAlD
Gemcitabine—SLC29A1—head—thyroid cancer	0.000586	0.0118	CbGeAlD
Gemcitabine—DCK—head—thyroid cancer	0.00056	0.0113	CbGeAlD
Gemcitabine—RRM1—lymph node—thyroid cancer	0.000505	0.0102	CbGeAlD
Gemcitabine—TYMS—lymph node—thyroid cancer	0.000458	0.00923	CbGeAlD
Gemcitabine—SLC29A1—lymph node—thyroid cancer	0.00041	0.00828	CbGeAlD
Gemcitabine—TYMS—Afatinib—Vandetanib—thyroid cancer	0.000407	0.118	CbGdCrCtD
Gemcitabine—DCK—lymph node—thyroid cancer	0.000392	0.00791	CbGeAlD
Gemcitabine—ABCC10—lymph node—thyroid cancer	0.000374	0.00754	CbGeAlD
Gemcitabine—TYMS—Gefitinib—Vandetanib—thyroid cancer	0.000356	0.103	CbGdCrCtD
Gemcitabine—SLC29A1—Fluoropyrimidine Activity—TP53—thyroid cancer	0.000236	0.00396	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—HPGD—thyroid cancer	0.000235	0.00395	CbGpPWpGaD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—CDK1—thyroid cancer	0.000233	0.00392	CbGpPWpGaD
Gemcitabine—POLD1—Chromosome Maintenance—TERT—thyroid cancer	0.000232	0.0039	CbGpPWpGaD
Gemcitabine—Extravasation—Epirubicin—thyroid cancer	0.000228	0.00195	CcSEcCtD
Gemcitabine—CDA—Metabolism—MINPP1—thyroid cancer	0.000225	0.00379	CbGpPWpGaD
Gemcitabine—Body temperature increased—Vandetanib—thyroid cancer	0.000225	0.00192	CcSEcCtD
Gemcitabine—POLE—Chromosome Maintenance—TERT—thyroid cancer	0.000224	0.00376	CbGpPWpGaD
Gemcitabine—Petechiae—Doxorubicin—thyroid cancer	0.000223	0.00191	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle, Mitotic—PCM1—thyroid cancer	0.000222	0.00373	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—PCM1—thyroid cancer	0.000221	0.00371	CbGpPWpGaD
Gemcitabine—Bone disorder—Epirubicin—thyroid cancer	0.00022	0.00188	CcSEcCtD
Gemcitabine—ABCB1—trachea—thyroid cancer	0.000219	0.00443	CbGeAlD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000219	0.00367	CbGpPWpGaD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000219	0.00367	CbGpPWpGaD
Gemcitabine—Hyperbilirubinaemia—Epirubicin—thyroid cancer	0.000218	0.00187	CcSEcCtD
Gemcitabine—Cellulitis—Epirubicin—thyroid cancer	0.000218	0.00187	CcSEcCtD
Gemcitabine—Anaemia—Sorafenib—thyroid cancer	0.000217	0.00186	CcSEcCtD
Gemcitabine—Hypocalcaemia—Epirubicin—thyroid cancer	0.000217	0.00186	CcSEcCtD
Gemcitabine—Neoplasm malignant—Doxorubicin—thyroid cancer	0.000215	0.00184	CcSEcCtD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000215	0.00361	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000214	0.00359	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—PCM1—thyroid cancer	0.000213	0.00358	CbGpPWpGaD
Gemcitabine—RRM2—Fluoropyrimidine Activity—TP53—thyroid cancer	0.000212	0.00357	CbGpPWpGaD
Gemcitabine—Extravasation—Doxorubicin—thyroid cancer	0.000211	0.0018	CcSEcCtD
Gemcitabine—Leukopenia—Sorafenib—thyroid cancer	0.00021	0.0018	CcSEcCtD
Gemcitabine—Blood bilirubin increased—Epirubicin—thyroid cancer	0.00021	0.0018	CcSEcCtD
Gemcitabine—Ulcer—Epirubicin—thyroid cancer	0.00021	0.0018	CcSEcCtD
Gemcitabine—Creatinine increased—Epirubicin—thyroid cancer	0.000209	0.00178	CcSEcCtD
Gemcitabine—Bone pain—Epirubicin—thyroid cancer	0.000207	0.00177	CcSEcCtD
Gemcitabine—Cough—Sorafenib—thyroid cancer	0.000205	0.00175	CcSEcCtD
Gemcitabine—Asthenia—Vandetanib—thyroid cancer	0.000204	0.00174	CcSEcCtD
Gemcitabine—Bone disorder—Doxorubicin—thyroid cancer	0.000203	0.00174	CcSEcCtD
Gemcitabine—POLA1—G1/S Transition—CDK1—thyroid cancer	0.000203	0.00342	CbGpPWpGaD
Gemcitabine—Hypertension—Sorafenib—thyroid cancer	0.000203	0.00173	CcSEcCtD
Gemcitabine—Cellulitis—Doxorubicin—thyroid cancer	0.000202	0.00173	CcSEcCtD
Gemcitabine—Hyperbilirubinaemia—Doxorubicin—thyroid cancer	0.000202	0.00173	CcSEcCtD
Gemcitabine—Pruritus—Vandetanib—thyroid cancer	0.000201	0.00172	CcSEcCtD
Gemcitabine—Hypocalcaemia—Doxorubicin—thyroid cancer	0.000201	0.00172	CcSEcCtD
Gemcitabine—Arthralgia—Sorafenib—thyroid cancer	0.0002	0.00171	CcSEcCtD
Gemcitabine—Myalgia—Sorafenib—thyroid cancer	0.0002	0.00171	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.000199	0.0017	CcSEcCtD
Gemcitabine—Phosphatase alkaline increased—Epirubicin—thyroid cancer	0.000199	0.0017	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle—PCM1—thyroid cancer	0.000198	0.00333	CbGpPWpGaD
Gemcitabine—Injection site reaction—Epirubicin—thyroid cancer	0.000197	0.00169	CcSEcCtD
Gemcitabine—POLD1—Cell Cycle—PCM1—thyroid cancer	0.000197	0.00331	CbGpPWpGaD
Gemcitabine—TYMS—G1/S Transition—CDK1—thyroid cancer	0.000195	0.00327	CbGpPWpGaD
Gemcitabine—Diarrhoea—Vandetanib—thyroid cancer	0.000194	0.00166	CcSEcCtD
Gemcitabine—Blood bilirubin increased—Doxorubicin—thyroid cancer	0.000194	0.00166	CcSEcCtD
Gemcitabine—Ulcer—Doxorubicin—thyroid cancer	0.000194	0.00166	CcSEcCtD
Gemcitabine—Creatinine increased—Doxorubicin—thyroid cancer	0.000193	0.00165	CcSEcCtD
Gemcitabine—Influenza like illness—Epirubicin—thyroid cancer	0.000193	0.00165	CcSEcCtD
Gemcitabine—Bone pain—Doxorubicin—thyroid cancer	0.000192	0.00164	CcSEcCtD
Gemcitabine—Anaphylactic shock—Sorafenib—thyroid cancer	0.000192	0.00164	CcSEcCtD
Gemcitabine—CDA—Metabolism—NDUFA13—thyroid cancer	0.000192	0.00322	CbGpPWpGaD
Gemcitabine—POLA1—Telomere Maintenance—TERT—thyroid cancer	0.000191	0.00322	CbGpPWpGaD
Gemcitabine—Infection—Sorafenib—thyroid cancer	0.00019	0.00163	CcSEcCtD
Gemcitabine—POLE—Cell Cycle—PCM1—thyroid cancer	0.00019	0.0032	CbGpPWpGaD
Gemcitabine—Skin exfoliation—Epirubicin—thyroid cancer	0.00019	0.00162	CcSEcCtD
Gemcitabine—Fluid retention—Epirubicin—thyroid cancer	0.000189	0.00161	CcSEcCtD
Gemcitabine—Nervous system disorder—Sorafenib—thyroid cancer	0.000188	0.00161	CcSEcCtD
Gemcitabine—Thrombocytopenia—Sorafenib—thyroid cancer	0.000188	0.00161	CcSEcCtD
Gemcitabine—Blood urea increased—Epirubicin—thyroid cancer	0.000187	0.0016	CcSEcCtD
Gemcitabine—Neuropathy—Epirubicin—thyroid cancer	0.000186	0.00159	CcSEcCtD
Gemcitabine—Skin disorder—Sorafenib—thyroid cancer	0.000186	0.00159	CcSEcCtD
Gemcitabine—Phosphatase alkaline increased—Doxorubicin—thyroid cancer	0.000184	0.00157	CcSEcCtD
Gemcitabine—Anorexia—Sorafenib—thyroid cancer	0.000183	0.00156	CcSEcCtD
Gemcitabine—Injection site reaction—Doxorubicin—thyroid cancer	0.000183	0.00156	CcSEcCtD
Gemcitabine—SLC29A1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000182	0.00306	CbGpPWpGaD
Gemcitabine—Vomiting—Vandetanib—thyroid cancer	0.000181	0.00155	CcSEcCtD
Gemcitabine—CDA—Metabolism—CHST14—thyroid cancer	0.00018	0.00303	CbGpPWpGaD
Gemcitabine—RRM1—Retinoblastoma (RB) in Cancer—CCND1—thyroid cancer	0.00018	0.00303	CbGpPWpGaD
Gemcitabine—Rash—Vandetanib—thyroid cancer	0.000179	0.00153	CcSEcCtD
Gemcitabine—Dermatitis—Vandetanib—thyroid cancer	0.000179	0.00153	CcSEcCtD
Gemcitabine—Influenza like illness—Doxorubicin—thyroid cancer	0.000178	0.00153	CcSEcCtD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000178	0.00299	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—CP—thyroid cancer	0.000178	0.00299	CbGpPWpGaD
Gemcitabine—Headache—Vandetanib—thyroid cancer	0.000178	0.00152	CcSEcCtD
Gemcitabine—Pulmonary oedema—Epirubicin—thyroid cancer	0.000177	0.00151	CcSEcCtD
Gemcitabine—Skin exfoliation—Doxorubicin—thyroid cancer	0.000175	0.0015	CcSEcCtD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000175	0.00295	CbGpPWpGaD
Gemcitabine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000175	0.00149	CcSEcCtD
Gemcitabine—Fluid retention—Doxorubicin—thyroid cancer	0.000174	0.00149	CcSEcCtD
Gemcitabine—POLE—Mitotic M-M/G1 phases—TPR—thyroid cancer	0.000174	0.00292	CbGpPWpGaD
Gemcitabine—ABCB1—thyroid gland—thyroid cancer	0.000174	0.0035	CbGeAlD
Gemcitabine—Blood urea increased—Doxorubicin—thyroid cancer	0.000173	0.00148	CcSEcCtD
Gemcitabine—POLE—G1 to S cell cycle control—CCND1—thyroid cancer	0.000173	0.00291	CbGpPWpGaD
Gemcitabine—Neuropathy—Doxorubicin—thyroid cancer	0.000173	0.00148	CcSEcCtD
Gemcitabine—Sepsis—Epirubicin—thyroid cancer	0.000172	0.00147	CcSEcCtD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—CDK1—thyroid cancer	0.000171	0.00288	CbGpPWpGaD
Gemcitabine—Dyspnoea—Sorafenib—thyroid cancer	0.000171	0.00146	CcSEcCtD
Gemcitabine—RRM1—Metabolism—MINPP1—thyroid cancer	0.000171	0.00287	CbGpPWpGaD
Gemcitabine—Nausea—Vandetanib—thyroid cancer	0.000169	0.00144	CcSEcCtD
Gemcitabine—Decreased appetite—Sorafenib—thyroid cancer	0.000167	0.00143	CcSEcCtD
Gemcitabine—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.000166	0.00142	CcSEcCtD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—CP—thyroid cancer	0.000166	0.00278	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000166	0.00278	CbGpPWpGaD
Gemcitabine—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000165	0.00142	CcSEcCtD
Gemcitabine—Fatigue—Sorafenib—thyroid cancer	0.000165	0.00141	CcSEcCtD
Gemcitabine—Hepatic function abnormal—Epirubicin—thyroid cancer	0.000165	0.00141	CcSEcCtD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—CDK1—thyroid cancer	0.000164	0.00276	CbGpPWpGaD
Gemcitabine—Constipation—Sorafenib—thyroid cancer	0.000164	0.0014	CcSEcCtD
Gemcitabine—Pain—Sorafenib—thyroid cancer	0.000164	0.0014	CcSEcCtD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000164	0.00275	CbGpPWpGaD
Gemcitabine—Pulmonary oedema—Doxorubicin—thyroid cancer	0.000164	0.0014	CcSEcCtD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000163	0.00274	CbGpPWpGaD
Gemcitabine—Hepatic failure—Epirubicin—thyroid cancer	0.00016	0.00137	CcSEcCtD
Gemcitabine—POLA1—Chromosome Maintenance—TERT—thyroid cancer	0.000159	0.00268	CbGpPWpGaD
Gemcitabine—Sepsis—Doxorubicin—thyroid cancer	0.000159	0.00136	CcSEcCtD
Gemcitabine—Cardiac failure congestive—Epirubicin—thyroid cancer	0.000159	0.00136	CcSEcCtD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000156	0.00262	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—CP—thyroid cancer	0.000156	0.00262	CbGpPWpGaD
Gemcitabine—ABCB1—head—thyroid cancer	0.000154	0.00311	CbGeAlD
Gemcitabine—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.000153	0.00131	CcSEcCtD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000153	0.00257	CbGpPWpGaD
Gemcitabine—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.000153	0.00131	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle, Mitotic—PCM1—thyroid cancer	0.000152	0.00255	CbGpPWpGaD
Gemcitabine—Body temperature increased—Sorafenib—thyroid cancer	0.000152	0.0013	CcSEcCtD
Gemcitabine—Renal impairment—Epirubicin—thyroid cancer	0.000151	0.0013	CcSEcCtD
Gemcitabine—Dermatitis bullous—Epirubicin—thyroid cancer	0.000151	0.00129	CcSEcCtD
Gemcitabine—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.000149	0.00127	CcSEcCtD
Gemcitabine—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000149	0.0025	CbGpPWpGaD
Gemcitabine—Hepatic failure—Doxorubicin—thyroid cancer	0.000148	0.00127	CcSEcCtD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—CCND1—thyroid cancer	0.000148	0.00249	CbGpPWpGaD
Gemcitabine—Cardiac failure—Epirubicin—thyroid cancer	0.000148	0.00126	CcSEcCtD
Gemcitabine—Cerebrovascular accident—Epirubicin—thyroid cancer	0.000147	0.00126	CcSEcCtD
Gemcitabine—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.000147	0.00126	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle, Mitotic—PCM1—thyroid cancer	0.000145	0.00244	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—HPGD—thyroid cancer	0.000145	0.00244	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—NDUFA13—thyroid cancer	0.000145	0.00244	CbGpPWpGaD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—CCND1—thyroid cancer	0.000142	0.00239	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—MINPP1—thyroid cancer	0.000141	0.00236	CbGpPWpGaD
Gemcitabine—DCK—Doxorubicin—Epirubicin—thyroid cancer	0.00014	0.0408	CbGdCrCtD
Gemcitabine—Renal impairment—Doxorubicin—thyroid cancer	0.00014	0.0012	CcSEcCtD
Gemcitabine—POLD1—Metabolism—MINPP1—thyroid cancer	0.00014	0.00235	CbGpPWpGaD
Gemcitabine—Dermatitis bullous—Doxorubicin—thyroid cancer	0.00014	0.00119	CcSEcCtD
Gemcitabine—Face oedema—Epirubicin—thyroid cancer	0.000139	0.00119	CcSEcCtD
Gemcitabine—TYMS—Fluoropyrimidine Activity—TP53—thyroid cancer	0.000139	0.00234	CbGpPWpGaD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—thyroid cancer	0.000139	0.00233	CbGpPWpGaD
Gemcitabine—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.000138	0.00118	CcSEcCtD
Gemcitabine—Asthenia—Sorafenib—thyroid cancer	0.000138	0.00118	CcSEcCtD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000137	0.00231	CbGpPWpGaD
Gemcitabine—Cardiac failure—Doxorubicin—thyroid cancer	0.000137	0.00117	CcSEcCtD
Gemcitabine—RRM1—Metabolism—CHST14—thyroid cancer	0.000137	0.0023	CbGpPWpGaD
Gemcitabine—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.000136	0.00116	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle—PCM1—thyroid cancer	0.000136	0.00228	CbGpPWpGaD
Gemcitabine—Pruritus—Sorafenib—thyroid cancer	0.000136	0.00116	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle, Mitotic—TPR—thyroid cancer	0.000136	0.00228	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—TPR—thyroid cancer	0.000135	0.00227	CbGpPWpGaD
Gemcitabine—Blood creatinine increased—Epirubicin—thyroid cancer	0.000135	0.00116	CcSEcCtD
Gemcitabine—POLD1—Cell Cycle, Mitotic—TPR—thyroid cancer	0.000135	0.00226	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000133	0.00224	CbGpPWpGaD
Gemcitabine—Liver function test abnormal—Epirubicin—thyroid cancer	0.000133	0.00114	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—PRKAR1A—thyroid cancer	0.000133	0.00223	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.000132	0.00223	CbGpPWpGaD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	0.000132	0.00222	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—MINPP1—thyroid cancer	0.000131	0.00221	CbGpPWpGaD
Gemcitabine—Hypokalaemia—Epirubicin—thyroid cancer	0.000131	0.00112	CcSEcCtD
Gemcitabine—Diarrhoea—Sorafenib—thyroid cancer	0.000131	0.00112	CcSEcCtD
Gemcitabine—POLE—Cell Cycle, Mitotic—TPR—thyroid cancer	0.00013	0.00219	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—PCM1—thyroid cancer	0.00013	0.00219	CbGpPWpGaD
Gemcitabine—DCK—Epirubicin—Doxorubicin—thyroid cancer	0.00013	0.0377	CbGdCrCtD
Gemcitabine—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00013	0.00111	CcSEcCtD
Gemcitabine—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00013	0.00111	CcSEcCtD
Gemcitabine—Face oedema—Doxorubicin—thyroid cancer	0.000129	0.0011	CcSEcCtD
Gemcitabine—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000127	0.00109	CcSEcCtD
Gemcitabine—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000125	0.00107	CcSEcCtD
Gemcitabine—Influenza—Epirubicin—thyroid cancer	0.000125	0.00107	CcSEcCtD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000124	0.00208	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—TPR—thyroid cancer	0.000124	0.00208	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000123	0.00208	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000123	0.00208	CbGpPWpGaD
Gemcitabine—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000123	0.00105	CcSEcCtD
Gemcitabine—Vomiting—Sorafenib—thyroid cancer	0.000122	0.00104	CcSEcCtD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000121	0.00204	CbGpPWpGaD
Gemcitabine—Hypokalaemia—Doxorubicin—thyroid cancer	0.000121	0.00104	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle—TPR—thyroid cancer	0.000121	0.00204	CbGpPWpGaD
Gemcitabine—Rash—Sorafenib—thyroid cancer	0.000121	0.00103	CcSEcCtD
Gemcitabine—Dermatitis—Sorafenib—thyroid cancer	0.000121	0.00103	CcSEcCtD
Gemcitabine—POLD1—Cell Cycle—TPR—thyroid cancer	0.00012	0.00202	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.00012	0.00202	CbGpPWpGaD
Gemcitabine—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00012	0.00103	CcSEcCtD
Gemcitabine—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.00012	0.00103	CcSEcCtD
Gemcitabine—Headache—Sorafenib—thyroid cancer	0.00012	0.00103	CcSEcCtD
Gemcitabine—RRM2—Metabolism—NDUFA13—thyroid cancer	0.00012	0.00201	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—NDUFA13—thyroid cancer	0.000119	0.002	CbGpPWpGaD
Gemcitabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—thyroid cancer	0.000119	0.00199	CbGpPWpGaD
Gemcitabine—Pancytopenia—Epirubicin—thyroid cancer	0.000118	0.00101	CcSEcCtD
Gemcitabine—POLE—Mitotic M-M/G1 phases—CDK1—thyroid cancer	0.000118	0.00198	CbGpPWpGaD
Gemcitabine—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000118	0.00101	CcSEcCtD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000117	0.00196	CbGpPWpGaD
Gemcitabine—Neutropenia—Epirubicin—thyroid cancer	0.000116	0.000997	CcSEcCtD
Gemcitabine—POLE—Cell Cycle—TPR—thyroid cancer	0.000116	0.00196	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000115	0.00194	CbGpPWpGaD
Gemcitabine—Influenza—Doxorubicin—thyroid cancer	0.000115	0.000986	CcSEcCtD
Gemcitabine—POLE—G1 to S cell cycle control—TP53—thyroid cancer	0.000114	0.00192	CbGpPWpGaD
Gemcitabine—Nausea—Sorafenib—thyroid cancer	0.000114	0.000974	CcSEcCtD
Gemcitabine—RRM2—Metabolism—CHST14—thyroid cancer	0.000112	0.00189	CbGpPWpGaD
Gemcitabine—Hyperglycaemia—Epirubicin—thyroid cancer	0.000112	0.000961	CcSEcCtD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000112	0.00188	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CHST14—thyroid cancer	0.000112	0.00188	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—NDUFA13—thyroid cancer	0.000112	0.00188	CbGpPWpGaD
Gemcitabine—Pneumonia—Epirubicin—thyroid cancer	0.000112	0.000956	CcSEcCtD
Gemcitabine—POLD1—S Phase—CCND1—thyroid cancer	0.000112	0.00188	CbGpPWpGaD
Gemcitabine—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00011	0.000942	CcSEcCtD
Gemcitabine—RRM1—Metabolism—HPGD—thyroid cancer	0.00011	0.00185	CbGpPWpGaD
Gemcitabine—Pancytopenia—Doxorubicin—thyroid cancer	0.000109	0.000937	CcSEcCtD
Gemcitabine—Renal failure—Epirubicin—thyroid cancer	0.000109	0.000934	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000109	0.000932	CcSEcCtD
Gemcitabine—Stomatitis—Epirubicin—thyroid cancer	0.000108	0.000926	CcSEcCtD
Gemcitabine—POLE—S Phase—CCND1—thyroid cancer	0.000108	0.00181	CbGpPWpGaD
Gemcitabine—ABCB1—lymph node—thyroid cancer	0.000108	0.00218	CbGeAlD
Gemcitabine—Neutropenia—Doxorubicin—thyroid cancer	0.000108	0.000922	CcSEcCtD
Gemcitabine—Sweating—Epirubicin—thyroid cancer	0.000106	0.000911	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000106	0.00179	CbGpPWpGaD
Gemcitabine—Haematuria—Epirubicin—thyroid cancer	0.000106	0.000906	CcSEcCtD
Gemcitabine—DCK—Metabolism—CHST14—thyroid cancer	0.000105	0.00177	CbGpPWpGaD
Gemcitabine—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000105	0.000899	CcSEcCtD
Gemcitabine—RRM2—Mitotic G1-G1/S phases—CCND1—thyroid cancer	0.000104	0.00175	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000104	0.00175	CbGpPWpGaD
Gemcitabine—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000104	0.00089	CcSEcCtD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.000104	0.00175	CbGpPWpGaD
Gemcitabine—Agranulocytosis—Epirubicin—thyroid cancer	0.000104	0.000887	CcSEcCtD
Gemcitabine—Pneumonia—Doxorubicin—thyroid cancer	0.000103	0.000884	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000102	0.000872	CcSEcCtD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—thyroid cancer	0.000101	0.0017	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—SLC5A5—thyroid cancer	0.000101	0.0017	CbGpPWpGaD
Gemcitabine—Renal failure—Doxorubicin—thyroid cancer	0.000101	0.000864	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000101	0.000862	CcSEcCtD
Gemcitabine—Haemoglobin—Epirubicin—thyroid cancer	0.0001	0.000857	CcSEcCtD
Gemcitabine—Stomatitis—Doxorubicin—thyroid cancer	0.0001	0.000857	CcSEcCtD
Gemcitabine—POLE—Mitotic G1-G1/S phases—CCND1—thyroid cancer	0.0001	0.00168	CbGpPWpGaD
Gemcitabine—Rhinitis—Epirubicin—thyroid cancer	0.0001	0.000855	CcSEcCtD
Gemcitabine—Haemorrhage—Epirubicin—thyroid cancer	9.97e-05	0.000853	CcSEcCtD
Gemcitabine—Pharyngitis—Epirubicin—thyroid cancer	9.9e-05	0.000847	CcSEcCtD
Gemcitabine—Sweating—Doxorubicin—thyroid cancer	9.85e-05	0.000843	CcSEcCtD
Gemcitabine—Urinary tract disorder—Epirubicin—thyroid cancer	9.85e-05	0.000842	CcSEcCtD
Gemcitabine—Oedema peripheral—Epirubicin—thyroid cancer	9.82e-05	0.00084	CcSEcCtD
Gemcitabine—Haematuria—Doxorubicin—thyroid cancer	9.8e-05	0.000838	CcSEcCtD
Gemcitabine—Connective tissue disorder—Epirubicin—thyroid cancer	9.8e-05	0.000838	CcSEcCtD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—RXRA—thyroid cancer	9.79e-05	0.00165	CbGpPWpGaD
Gemcitabine—Urethral disorder—Epirubicin—thyroid cancer	9.77e-05	0.000836	CcSEcCtD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—thyroid cancer	9.77e-05	0.00164	CbGpPWpGaD
Gemcitabine—Hepatobiliary disease—Doxorubicin—thyroid cancer	9.72e-05	0.000832	CcSEcCtD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—CCND1—thyroid cancer	9.71e-05	0.00163	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	9.6e-05	0.00161	CbGpPWpGaD
Gemcitabine—Agranulocytosis—Doxorubicin—thyroid cancer	9.59e-05	0.000821	CcSEcCtD
Gemcitabine—Erythema multiforme—Epirubicin—thyroid cancer	9.43e-05	0.000807	CcSEcCtD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—TP53—thyroid cancer	9.37e-05	0.00158	CbGpPWpGaD
Gemcitabine—Haemoglobin—Doxorubicin—thyroid cancer	9.27e-05	0.000793	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle, Mitotic—TPR—thyroid cancer	9.27e-05	0.00156	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	9.26e-05	0.00156	CbGpPWpGaD
Gemcitabine—Cardiac disorder—Epirubicin—thyroid cancer	9.25e-05	0.000792	CcSEcCtD
Gemcitabine—Rhinitis—Doxorubicin—thyroid cancer	9.25e-05	0.000791	CcSEcCtD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	9.24e-05	0.00155	CbGpPWpGaD
Gemcitabine—Haemorrhage—Doxorubicin—thyroid cancer	9.23e-05	0.000789	CcSEcCtD
Gemcitabine—TYMS—Metabolism—MINPP1—thyroid cancer	9.22e-05	0.00155	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDK1—thyroid cancer	9.18e-05	0.00154	CbGpPWpGaD
Gemcitabine—Pharyngitis—Doxorubicin—thyroid cancer	9.16e-05	0.000783	CcSEcCtD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDK1—thyroid cancer	9.13e-05	0.00153	CbGpPWpGaD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—thyroid cancer	9.13e-05	0.00153	CbGpPWpGaD
Gemcitabine—Urinary tract disorder—Doxorubicin—thyroid cancer	9.11e-05	0.00078	CcSEcCtD
Gemcitabine—Oedema peripheral—Doxorubicin—thyroid cancer	9.09e-05	0.000778	CcSEcCtD
Gemcitabine—Connective tissue disorder—Doxorubicin—thyroid cancer	9.07e-05	0.000776	CcSEcCtD
Gemcitabine—RRM2—Metabolism—HPGD—thyroid cancer	9.07e-05	0.00152	CbGpPWpGaD
Gemcitabine—Angiopathy—Epirubicin—thyroid cancer	9.05e-05	0.000774	CcSEcCtD
Gemcitabine—Urethral disorder—Doxorubicin—thyroid cancer	9.04e-05	0.000774	CcSEcCtD
Gemcitabine—POLD1—Metabolism—HPGD—thyroid cancer	9.01e-05	0.00151	CbGpPWpGaD
Gemcitabine—Immune system disorder—Epirubicin—thyroid cancer	9.01e-05	0.000771	CcSEcCtD
Gemcitabine—Mediastinal disorder—Epirubicin—thyroid cancer	8.99e-05	0.000769	CcSEcCtD
Gemcitabine—Chills—Epirubicin—thyroid cancer	8.95e-05	0.000765	CcSEcCtD
Gemcitabine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	8.94e-05	0.0015	CbGpPWpGaD
Gemcitabine—Arrhythmia—Epirubicin—thyroid cancer	8.91e-05	0.000762	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle, Mitotic—TPR—thyroid cancer	8.88e-05	0.00149	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDK1—thyroid cancer	8.82e-05	0.00148	CbGpPWpGaD
Gemcitabine—Alopecia—Epirubicin—thyroid cancer	8.81e-05	0.000754	CcSEcCtD
Gemcitabine—Erythema multiforme—Doxorubicin—thyroid cancer	8.72e-05	0.000746	CcSEcCtD
Gemcitabine—Erythema—Epirubicin—thyroid cancer	8.68e-05	0.000743	CcSEcCtD
Gemcitabine—Cardiac disorder—Doxorubicin—thyroid cancer	8.56e-05	0.000733	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—RXRA—thyroid cancer	8.49e-05	0.00143	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—HPGD—thyroid cancer	8.47e-05	0.00142	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—CDK1—thyroid cancer	8.4e-05	0.00141	CbGpPWpGaD
Gemcitabine—Back pain—Epirubicin—thyroid cancer	8.4e-05	0.000718	CcSEcCtD
Gemcitabine—Angiopathy—Doxorubicin—thyroid cancer	8.37e-05	0.000716	CcSEcCtD
Gemcitabine—CDA—Metabolism—TPR—thyroid cancer	8.34e-05	0.0014	CbGpPWpGaD
Gemcitabine—Immune system disorder—Doxorubicin—thyroid cancer	8.33e-05	0.000713	CcSEcCtD
Gemcitabine—Mediastinal disorder—Doxorubicin—thyroid cancer	8.32e-05	0.000711	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle—TPR—thyroid cancer	8.29e-05	0.00139	CbGpPWpGaD
Gemcitabine—Chills—Doxorubicin—thyroid cancer	8.28e-05	0.000708	CcSEcCtD
Gemcitabine—Arrhythmia—Doxorubicin—thyroid cancer	8.24e-05	0.000705	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle—CDK1—thyroid cancer	8.21e-05	0.00138	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PRKAR1A—thyroid cancer	8.21e-05	0.00138	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDK1—thyroid cancer	8.16e-05	0.00137	CbGpPWpGaD
Gemcitabine—Alopecia—Doxorubicin—thyroid cancer	8.15e-05	0.000698	CcSEcCtD
Gemcitabine—Ill-defined disorder—Epirubicin—thyroid cancer	8.05e-05	0.000689	CcSEcCtD
Gemcitabine—Erythema—Doxorubicin—thyroid cancer	8.03e-05	0.000687	CcSEcCtD
Gemcitabine—Anaemia—Epirubicin—thyroid cancer	8.02e-05	0.000686	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle—TPR—thyroid cancer	7.94e-05	0.00133	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDK1—thyroid cancer	7.88e-05	0.00133	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—NDUFA13—thyroid cancer	7.84e-05	0.00132	CbGpPWpGaD
Gemcitabine—Malaise—Epirubicin—thyroid cancer	7.83e-05	0.00067	CcSEcCtD
Gemcitabine—Leukopenia—Epirubicin—thyroid cancer	7.77e-05	0.000665	CcSEcCtD
Gemcitabine—Back pain—Doxorubicin—thyroid cancer	7.77e-05	0.000665	CcSEcCtD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.77e-05	0.00131	CbGpPWpGaD
Gemcitabine—POLA1—S Phase—CCND1—thyroid cancer	7.69e-05	0.00129	CbGpPWpGaD
Gemcitabine—Cough—Epirubicin—thyroid cancer	7.57e-05	0.000648	CcSEcCtD
Gemcitabine—Hypertension—Epirubicin—thyroid cancer	7.49e-05	0.000641	CcSEcCtD
Gemcitabine—Ill-defined disorder—Doxorubicin—thyroid cancer	7.45e-05	0.000638	CcSEcCtD
Gemcitabine—Anaemia—Doxorubicin—thyroid cancer	7.42e-05	0.000635	CcSEcCtD
Gemcitabine—Arthralgia—Epirubicin—thyroid cancer	7.39e-05	0.000632	CcSEcCtD
Gemcitabine—Myalgia—Epirubicin—thyroid cancer	7.39e-05	0.000632	CcSEcCtD
Gemcitabine—Chest pain—Epirubicin—thyroid cancer	7.39e-05	0.000632	CcSEcCtD
Gemcitabine—TYMS—Metabolism—CHST14—thyroid cancer	7.37e-05	0.00124	CbGpPWpGaD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	7.34e-05	0.000628	CcSEcCtD
Gemcitabine—Discomfort—Epirubicin—thyroid cancer	7.3e-05	0.000625	CcSEcCtD
Gemcitabine—Malaise—Doxorubicin—thyroid cancer	7.24e-05	0.00062	CcSEcCtD
Gemcitabine—Leukopenia—Doxorubicin—thyroid cancer	7.19e-05	0.000615	CcSEcCtD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—CCND1—thyroid cancer	7.13e-05	0.0012	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	7.11e-05	0.0012	CbGpPWpGaD
Gemcitabine—Anaphylactic shock—Epirubicin—thyroid cancer	7.08e-05	0.000606	CcSEcCtD
Gemcitabine—Oedema—Epirubicin—thyroid cancer	7.08e-05	0.000606	CcSEcCtD
Gemcitabine—Infection—Epirubicin—thyroid cancer	7.04e-05	0.000602	CcSEcCtD
Gemcitabine—Cough—Doxorubicin—thyroid cancer	7.01e-05	0.0006	CcSEcCtD
Gemcitabine—TYMS—Circadian rythm related genes—PPARG—thyroid cancer	6.99e-05	0.00118	CbGpPWpGaD
Gemcitabine—Nervous system disorder—Epirubicin—thyroid cancer	6.95e-05	0.000594	CcSEcCtD
Gemcitabine—Thrombocytopenia—Epirubicin—thyroid cancer	6.94e-05	0.000593	CcSEcCtD
Gemcitabine—Hypertension—Doxorubicin—thyroid cancer	6.93e-05	0.000593	CcSEcCtD
Gemcitabine—Skin disorder—Epirubicin—thyroid cancer	6.88e-05	0.000589	CcSEcCtD
Gemcitabine—Hyperhidrosis—Epirubicin—thyroid cancer	6.85e-05	0.000586	CcSEcCtD
Gemcitabine—Chest pain—Doxorubicin—thyroid cancer	6.84e-05	0.000585	CcSEcCtD
Gemcitabine—Arthralgia—Doxorubicin—thyroid cancer	6.84e-05	0.000585	CcSEcCtD
Gemcitabine—Myalgia—Doxorubicin—thyroid cancer	6.84e-05	0.000585	CcSEcCtD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—CCND1—thyroid cancer	6.84e-05	0.00115	CbGpPWpGaD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	6.79e-05	0.000581	CcSEcCtD
Gemcitabine—Discomfort—Doxorubicin—thyroid cancer	6.76e-05	0.000578	CcSEcCtD
Gemcitabine—Anorexia—Epirubicin—thyroid cancer	6.75e-05	0.000578	CcSEcCtD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—thyroid cancer	6.68e-05	0.00112	CbGpPWpGaD
Gemcitabine—Hypotension—Epirubicin—thyroid cancer	6.62e-05	0.000566	CcSEcCtD
Gemcitabine—Oedema—Doxorubicin—thyroid cancer	6.56e-05	0.000561	CcSEcCtD
Gemcitabine—Anaphylactic shock—Doxorubicin—thyroid cancer	6.56e-05	0.000561	CcSEcCtD
Gemcitabine—Infection—Doxorubicin—thyroid cancer	6.51e-05	0.000557	CcSEcCtD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	6.47e-05	0.00109	CbGpPWpGaD
Gemcitabine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	6.45e-05	0.000552	CcSEcCtD
Gemcitabine—Nervous system disorder—Doxorubicin—thyroid cancer	6.43e-05	0.00055	CcSEcCtD
Gemcitabine—Thrombocytopenia—Doxorubicin—thyroid cancer	6.42e-05	0.000549	CcSEcCtD
Gemcitabine—Insomnia—Epirubicin—thyroid cancer	6.41e-05	0.000548	CcSEcCtD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—thyroid cancer	6.4e-05	0.00108	CbGpPWpGaD
Gemcitabine—Skin disorder—Doxorubicin—thyroid cancer	6.37e-05	0.000545	CcSEcCtD
Gemcitabine—Paraesthesia—Epirubicin—thyroid cancer	6.36e-05	0.000544	CcSEcCtD
Gemcitabine—Hyperhidrosis—Doxorubicin—thyroid cancer	6.34e-05	0.000542	CcSEcCtD
Gemcitabine—RRM1—Metabolism—TPR—thyroid cancer	6.32e-05	0.00106	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	6.32e-05	0.00106	CbGpPWpGaD
Gemcitabine—Dyspnoea—Epirubicin—thyroid cancer	6.32e-05	0.00054	CcSEcCtD
Gemcitabine—Somnolence—Epirubicin—thyroid cancer	6.3e-05	0.000539	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDK1—thyroid cancer	6.28e-05	0.00106	CbGpPWpGaD
Gemcitabine—Anorexia—Doxorubicin—thyroid cancer	6.25e-05	0.000535	CcSEcCtD
Gemcitabine—CDA—Metabolism—SLC5A5—thyroid cancer	6.25e-05	0.00105	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PRKAR1A—thyroid cancer	6.22e-05	0.00105	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	6.19e-05	0.00104	CbGpPWpGaD
Gemcitabine—Decreased appetite—Epirubicin—thyroid cancer	6.16e-05	0.000527	CcSEcCtD
Gemcitabine—Hypotension—Doxorubicin—thyroid cancer	6.13e-05	0.000524	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Epirubicin—thyroid cancer	6.12e-05	0.000523	CcSEcCtD
Gemcitabine—Fatigue—Epirubicin—thyroid cancer	6.11e-05	0.000523	CcSEcCtD
Gemcitabine—Constipation—Epirubicin—thyroid cancer	6.06e-05	0.000518	CcSEcCtD
Gemcitabine—Pain—Epirubicin—thyroid cancer	6.06e-05	0.000518	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDK1—thyroid cancer	6.02e-05	0.00101	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	5.98e-05	0.00101	CbGpPWpGaD
Gemcitabine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	5.97e-05	0.000511	CcSEcCtD
Gemcitabine—TYMS—Metabolism—HPGD—thyroid cancer	5.94e-05	0.000999	CbGpPWpGaD
Gemcitabine—Insomnia—Doxorubicin—thyroid cancer	5.93e-05	0.000507	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle—TERT—thyroid cancer	5.92e-05	0.000995	CbGpPWpGaD
Gemcitabine—Paraesthesia—Doxorubicin—thyroid cancer	5.89e-05	0.000504	CcSEcCtD
Gemcitabine—POLD1—Cell Cycle—TERT—thyroid cancer	5.88e-05	0.000989	CbGpPWpGaD
Gemcitabine—Dyspnoea—Doxorubicin—thyroid cancer	5.84e-05	0.0005	CcSEcCtD
Gemcitabine—Feeling abnormal—Epirubicin—thyroid cancer	5.84e-05	0.000499	CcSEcCtD
Gemcitabine—Somnolence—Doxorubicin—thyroid cancer	5.83e-05	0.000499	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	5.73e-05	0.000963	CbGpPWpGaD
Gemcitabine—Decreased appetite—Doxorubicin—thyroid cancer	5.7e-05	0.000487	CcSEcCtD
Gemcitabine—POLE—Cell Cycle—TERT—thyroid cancer	5.68e-05	0.000955	CbGpPWpGaD
Gemcitabine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	5.66e-05	0.000484	CcSEcCtD
Gemcitabine—Fatigue—Doxorubicin—thyroid cancer	5.65e-05	0.000483	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle—CDK1—thyroid cancer	5.62e-05	0.000944	CbGpPWpGaD
Gemcitabine—Constipation—Doxorubicin—thyroid cancer	5.61e-05	0.00048	CcSEcCtD
Gemcitabine—Pain—Doxorubicin—thyroid cancer	5.61e-05	0.00048	CcSEcCtD
Gemcitabine—Body temperature increased—Epirubicin—thyroid cancer	5.6e-05	0.000479	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	5.41e-05	0.000909	CbGpPWpGaD
Gemcitabine—Feeling abnormal—Doxorubicin—thyroid cancer	5.4e-05	0.000462	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle—CDK1—thyroid cancer	5.38e-05	0.000905	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PPARG—thyroid cancer	5.36e-05	0.000901	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	5.34e-05	0.000897	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—RXRA—thyroid cancer	5.25e-05	0.000882	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	5.22e-05	0.000877	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—TPR—thyroid cancer	5.21e-05	0.000875	CbGpPWpGaD
Gemcitabine—Body temperature increased—Doxorubicin—thyroid cancer	5.18e-05	0.000443	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	5.18e-05	0.000871	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—TPR—thyroid cancer	5.17e-05	0.00087	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PRKAR1A—thyroid cancer	5.12e-05	0.000861	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PRKAR1A—thyroid cancer	5.09e-05	0.000856	CbGpPWpGaD
Gemcitabine—Asthenia—Epirubicin—thyroid cancer	5.08e-05	0.000435	CcSEcCtD
Gemcitabine—Pruritus—Epirubicin—thyroid cancer	5.01e-05	0.000429	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	5e-05	0.00084	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—TPR—thyroid cancer	4.87e-05	0.000818	CbGpPWpGaD
Gemcitabine—Diarrhoea—Epirubicin—thyroid cancer	4.85e-05	0.000415	CcSEcCtD
Gemcitabine—TYMS—Circadian rythm related genes—PTEN—thyroid cancer	4.8e-05	0.000807	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PRKAR1A—thyroid cancer	4.79e-05	0.000805	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—SLC5A5—thyroid cancer	4.73e-05	0.000796	CbGpPWpGaD
Gemcitabine—Asthenia—Doxorubicin—thyroid cancer	4.7e-05	0.000402	CcSEcCtD
Gemcitabine—Pruritus—Doxorubicin—thyroid cancer	4.64e-05	0.000397	CcSEcCtD
Gemcitabine—Vomiting—Epirubicin—thyroid cancer	4.5e-05	0.000385	CcSEcCtD
Gemcitabine—Diarrhoea—Doxorubicin—thyroid cancer	4.49e-05	0.000384	CcSEcCtD
Gemcitabine—Rash—Epirubicin—thyroid cancer	4.47e-05	0.000382	CcSEcCtD
Gemcitabine—Dermatitis—Epirubicin—thyroid cancer	4.46e-05	0.000382	CcSEcCtD
Gemcitabine—Headache—Epirubicin—thyroid cancer	4.44e-05	0.00038	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—PTGS2—thyroid cancer	4.22e-05	0.000709	CbGpPWpGaD
Gemcitabine—Nausea—Epirubicin—thyroid cancer	4.21e-05	0.00036	CcSEcCtD
Gemcitabine—Vomiting—Doxorubicin—thyroid cancer	4.17e-05	0.000357	CcSEcCtD
Gemcitabine—Rash—Doxorubicin—thyroid cancer	4.13e-05	0.000354	CcSEcCtD
Gemcitabine—Dermatitis—Doxorubicin—thyroid cancer	4.13e-05	0.000353	CcSEcCtD
Gemcitabine—Headache—Doxorubicin—thyroid cancer	4.11e-05	0.000351	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle—TERT—thyroid cancer	4.05e-05	0.00068	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	4.01e-05	0.000673	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—RXRA—thyroid cancer	3.98e-05	0.000668	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—SLC5A5—thyroid cancer	3.9e-05	0.000655	CbGpPWpGaD
Gemcitabine—Nausea—Doxorubicin—thyroid cancer	3.89e-05	0.000333	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle—TERT—thyroid cancer	3.88e-05	0.000652	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—SLC5A5—thyroid cancer	3.87e-05	0.000651	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	3.84e-05	0.000645	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CCND1—thyroid cancer	3.83e-05	0.000643	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CCND1—thyroid cancer	3.8e-05	0.000639	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PTEN—thyroid cancer	3.68e-05	0.000618	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CCND1—thyroid cancer	3.67e-05	0.000617	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—SLC5A5—thyroid cancer	3.64e-05	0.000612	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	3.56e-05	0.000599	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	3.56e-05	0.000599	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CCND1—thyroid cancer	3.42e-05	0.000575	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—TPR—thyroid cancer	3.41e-05	0.000574	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	3.41e-05	0.000573	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CCND1—thyroid cancer	3.4e-05	0.000572	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PRKAR1A—thyroid cancer	3.36e-05	0.000564	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PPARG—thyroid cancer	3.31e-05	0.000557	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CCND1—thyroid cancer	3.28e-05	0.000552	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—RXRA—thyroid cancer	3.27e-05	0.00055	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—TP53—thyroid cancer	3.27e-05	0.00055	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—RXRA—thyroid cancer	3.25e-05	0.000547	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—RXRA—thyroid cancer	3.06e-05	0.000514	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	3.01e-05	0.000505	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	2.88e-05	0.000484	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—MINPP1—thyroid cancer	2.84e-05	0.000478	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CCND1—thyroid cancer	2.62e-05	0.00044	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PTGS2—thyroid cancer	2.61e-05	0.000438	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—SLC5A5—thyroid cancer	2.55e-05	0.000429	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PPARG—thyroid cancer	2.51e-05	0.000422	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CCND1—thyroid cancer	2.51e-05	0.000421	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NDUFA13—thyroid cancer	2.42e-05	0.000407	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CCND1—thyroid cancer	2.34e-05	0.000393	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CHST14—thyroid cancer	2.27e-05	0.000382	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PTEN—thyroid cancer	2.27e-05	0.000382	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—TP53—thyroid cancer	2.25e-05	0.000379	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	2.25e-05	0.000378	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	2.25e-05	0.000378	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CCND1—thyroid cancer	2.24e-05	0.000377	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TP53—thyroid cancer	2.24e-05	0.000376	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	2.21e-05	0.000372	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—TP53—thyroid cancer	2.16e-05	0.000364	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—RXRA—thyroid cancer	2.15e-05	0.000361	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—AKT1—thyroid cancer	2.12e-05	0.000356	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	2.08e-05	0.00035	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PPARG—thyroid cancer	2.07e-05	0.000348	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PPARG—thyroid cancer	2.06e-05	0.000345	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTGS2—thyroid cancer	1.98e-05	0.000332	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PPARG—thyroid cancer	1.93e-05	0.000325	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—HPGD—thyroid cancer	1.83e-05	0.000308	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	1.77e-05	0.000297	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTEN—thyroid cancer	1.72e-05	0.00029	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.68e-05	0.000283	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTGS2—thyroid cancer	1.63e-05	0.000273	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTGS2—thyroid cancer	1.62e-05	0.000272	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	1.6e-05	0.000269	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	1.54e-05	0.000259	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TP53—thyroid cancer	1.54e-05	0.000259	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTGS2—thyroid cancer	1.52e-05	0.000256	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TP53—thyroid cancer	1.48e-05	0.000248	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTEN—thyroid cancer	1.42e-05	0.000238	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.41e-05	0.000238	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTEN—thyroid cancer	1.41e-05	0.000237	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PPARG—thyroid cancer	1.35e-05	0.000228	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTEN—thyroid cancer	1.33e-05	0.000223	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—AKT1—thyroid cancer	1.31e-05	0.00022	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.18e-05	0.000199	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTGS2—thyroid cancer	1.07e-05	0.000179	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—TPR—thyroid cancer	1.05e-05	0.000177	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.05e-05	0.000177	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PRKAR1A—thyroid cancer	1.04e-05	0.000174	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—AKT1—thyroid cancer	9.93e-06	0.000167	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTEN—thyroid cancer	9.29e-06	0.000156	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	8.89e-06	0.000149	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—AKT1—thyroid cancer	8.17e-06	0.000137	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—AKT1—thyroid cancer	8.12e-06	0.000137	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SLC5A5—thyroid cancer	7.88e-06	0.000132	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—AKT1—thyroid cancer	7.64e-06	0.000128	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—RXRA—thyroid cancer	6.62e-06	0.000111	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—AKT1—thyroid cancer	5.36e-06	9e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PPARG—thyroid cancer	4.18e-06	7.03e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTGS2—thyroid cancer	3.29e-06	5.53e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTEN—thyroid cancer	2.87e-06	4.82e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—AKT1—thyroid cancer	1.65e-06	2.78e-05	CbGpPWpGaD
